Page last updated: 2024-09-03

imatinib mesylate and Hemorrhagic Disorders

imatinib mesylate has been researched along with Hemorrhagic Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cortes, J; Kantarjian, H; Kornblau, S; O'Brien, S; Quintás-Cardama, A; Ravandi, F; Thomas, D; Vidal-Senmache, G; Wierda, W	1

Trials

1 trial(s) available for imatinib mesylate and Hemorrhagic Disorders

Article	Year
Bleeding diathesis in patients with chronic myelogenous leukemia receiving dasatinib therapy. Cancer, 2009, Jun-01, Volume: 115, Issue:11 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzamides; Dasatinib; Drug Resistance, Neoplasm; Female; Hemorrhagic Disorders; Humans; Imatinib Mesylate; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Piperazines; Platelet Count; Pyrimidines; Risk Factors; Thiazoles; Withholding Treatment; Young Adult	2009

Article

Year

Bleeding diathesis in patients with chronic myelogenous leukemia receiving dasatinib therapy.

Cancer, 2009, Jun-01, Volume: 115, Issue:11

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzamides; Dasatinib; Drug Resistance, Neoplasm; Female; Hemorrhagic Disorders; Humans; Imatinib Mesylate; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Piperazines; Platelet Count; Pyrimidines; Risk Factors; Thiazoles; Withholding Treatment; Young Adult

2009